Publications by authors named "Kent D Stewart"

Claim this Profile
P
Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder.
Comfort A Boateng, Ashley N Nilson, Rebekah Placide, Mimi L Pham, Franziska M Jakobs, Kent D Stewart

J Med Chem· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability.
John T Randolph, A Chris Krueger, Pamela L Donner, John K Pratt, Dachun Liu, Kent D Stewart

J Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif.
A Chris Krueger, John T Randolph, David A DeGoey, Pamela L Donner, Charles A Flentge, Kent D Stewart

Bioorg Med Chem Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195.
Yunsong Tong, Kent D Stewart, Alan S Florjancic, John E Harlan, Philip J Merta

ACS Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors.
Qingwei Zhang, Zhiren Xia, Michael J Mitten, Loren M Lasko, Vered Klinghofer, Kent D Stewart

Bioorg Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases.
Michael L Curtin, H Robin Heyman, Robin R Frey, Patrick A Marcotte, Keith B Glaser, Kent D Stewart

Bioorg Med Chem Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors.
Zhiqin Ji, Yujia Dai, Cele Abad-Zapatero, Daniel H Albert, Jennifer J Bouska, Kent D Stewart

Bioorg Med Chem Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of indazolinone tautomers to kinase activity.
Anil Vasudevan, Mary K Verzal, Clara I Villamil, Kent D Stewart, Cele Abad-Zapatero

Bioorg Med Chem Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families.
Michael L Curtin, Robin R Frey, H Robin Heyman, Niru B Soni, Patrick A Marcotte, Kent D Stewart

Bioorg Med Chem Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinases.
William J McClellan, Yujia Dai, Cele Abad-Zapatero, Daniel H Albert, Jennifer J Bouska, Kent D Stewart

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moiety.
Douglas K Hutchinson, Charles A Flentge, Pamela L Donner, Rolf Wagner, Clarence J Maring, Kent D Stewart

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cheminformatic tools for medicinal chemists.
Steven W Muchmore, Jeremy J Edmunds, Kent D Stewart, Philip J Hajduk

J Med Chem· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases.
Steve D Fidanze, Scott A Erickson, Gary T Wang, Robert Mantei, Richard F Clark, Kent D Stewart

Bioorg Med Chem Lett· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket.
Kent D Stewart, Jeffrey R Huth, Teresa I Ng, Keith McDaniel, Rebecca Newlin Hutchinson

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.
Zhi-Fu Tao, Lisa A Hasvold, Joel D Leverson, Edward K Han, Ran Guan, Kent D Stewart

J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
John T Randolph, Charles A Flentge, Peggy P Huang, Douglas K Hutchinson, Larry L Klein, Kent D Stewart

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.
Yunsong Tong, Kent D Stewart, Sheela Thomas, Magdalena Przytulinska, Eric F Johnson

Bioorg Med Chem Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
7
7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors.
Robin R Frey, Michael L Curtin, Daniel H Albert, Keith B Glaser, Lori J Pease, Kent D Stewart

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives.
Douglas K Hutchinson, Teresa Rosenberg, Larry L Klein, Todd D Bosse, Daniel P Larson, Kent D Stewart

Bioorg Med Chem Lett· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.
Vijaya Gracias, Zhiqin Ji, Irini Akritopoulou-Zanze, Cele Abad-Zapatero, Jeffrey R Huth, Kent D Stewart

Bioorg Med Chem Lett· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinases.
Zhiqin Ji, Asma A Ahmed, Daniel H Albert, Jennifer J Bouska, Peter F Bousquet, Kent D Stewart

J Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors.
Yujia Dai, Kresna Hartandi, Niru B Soni, Lori J Pease, David R Reuter, Kent D Stewart

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors.
Zhi-Fu Tao, Gaoquan Li, Yunsong Tong, Kent D Stewart, Zehan Chen

Bioorg Med Chem Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailability.
Yunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, Jennifer Bouska, Kent D Stewart

Bioorg Med Chem Lett· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors.
Le Wang, Gerard M Sullivan, Laura A Hexamer, Lisa A Hasvold, Reema Thalji, Kent D Stewart

J Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis